RecruitingNCT04709432

ECMO Treatment of Children in China in the Past 10 Years

Extracorporeal Membrane Oxygenation (ECMO) Treatment of Children in Mainland China in the Past 10 Years

Sponsor

Children's Hospital of Fudan University

Enrollment

500 participants

Start Date

Jan 11, 2021

Study Type

OBSERVATIONAL

Conditions

Child, Only Extracorporeal Membrane Oxygenation

Summary

It is a cross-sectional study to summarize the extracorporeal membrane oxygenation （ECMO）treatment in children in China.

Eligibility

Min Age: 1 DayMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called ECMO for people with child, only and extracorporeal membrane oxygenation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Day to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREECMO

ECMO is a form of Extracorporeal Life Support (ECLS) to support either the pulmonary, or both the pulmonary and cardiac systems.

Locations(1)

Children's Hospital of Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04709432

Related Trials

ECMO Treatment of Children in China in the Past 10 Years

Conditions

Summary

Eligibility

Plain Language Summary

Interventions

Locations(1)

Related Trials

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

Effects of Traditional Game in School Going Children

Pediatric Medication Therapy Management Trial

Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

Urine and Ultrasound Screening for Kidney Disease in Children